RF24 | PSUN96 Setmelanotide in Patients With Heterozygous POMC, LEPR, SRC1, or SH2B1 Obesity: Design of EMANATE – A Placebo-Controlled Phase 3 Trial

BACKGROUND: The central hypothalamic melanocortin-4 receptor (MC4R) pathway is a key regulator of energy balance. Certain variants in genes upstream of MC4R, including those encoding the leptin receptor (LEPR), proopiomelanocortin (POMC), steroid receptor coactivator 1 (SRC1; also known as NCOA1), p...

Descripción completa

Detalles Bibliográficos
Autores principales: Wabitsch, Martin, Farooqi, Sadaf, Argente, Jesús, van den Akker, Erica, Yuan, Guojun, Ohayon, Olga, Scimia, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624515/
http://dx.doi.org/10.1210/jendso/bvac150.076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624515/
http://dx.doi.org/10.1210/jendso/bvac150.076

Ejemplares similares